ery-ped

Generic: erythromycin ethylsuccinate

Labeler: carnegie pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name ery-ped
Generic Name erythromycin ethylsuccinate
Labeler carnegie pharmaceuticals llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

erythromycin ethylsuccinate 400 mg/5mL

Manufacturer
Carnegie Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 80005-155
Product ID 80005-155_d05c0828-9fce-4a60-a2ac-d9a1fbf17792
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA050207
Listing Expiration 2026-12-31
Marketing Start 2025-01-15

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] macrolide antimicrobial [epc] macrolide [epc] macrolides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 80005155
Hyphenated Format 80005-155

Supplemental Identifiers

RxCUI
686418 686420
UNII
1014KSJ86F

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ery-ped (source: ndc)
Generic Name erythromycin ethylsuccinate (source: ndc)
Application Number NDA050207 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/5mL
source: ndc
Packaging
  • 100 mL in 1 BOTTLE (80005-155-18)
source: ndc

Packages (1)

Ingredients (1)

erythromycin ethylsuccinate (400 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d05c0828-9fce-4a60-a2ac-d9a1fbf17792", "openfda": {"unii": ["1014KSJ86F"], "rxcui": ["686418", "686420"], "spl_set_id": ["94b4658c-f4f5-4257-a1e3-82fd3155dee6"], "manufacturer_name": ["Carnegie Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (80005-155-18)", "package_ndc": "80005-155-18", "marketing_start_date": "20250115"}], "brand_name": "Ery-Ped", "product_id": "80005-155_d05c0828-9fce-4a60-a2ac-d9a1fbf17792", "dosage_form": "SUSPENSION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "80005-155", "generic_name": "Erythromycin Ethylsuccinate", "labeler_name": "Carnegie Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ery-Ped", "active_ingredients": [{"name": "ERYTHROMYCIN ETHYLSUCCINATE", "strength": "400 mg/5mL"}], "application_number": "NDA050207", "marketing_category": "NDA", "marketing_start_date": "20250115", "listing_expiration_date": "20261231"}